Skip to main content
Clinical Trials/IRCT20230428058015N1
IRCT20230428058015N1CompletedPhase 3

Comparison of the effect of heparinized normal saline flushing with prophylactic dose enoxaparin subcutaneous injection in the prevention of central venous catheter thrombosis in hospitalized high-risk patients

Tehran University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 month to 18 years (—)
Sex
All

Inclusion Criteria

  • All patients with central venous catheter admitted to the intensive care unit
  • None of the bleeding risk factors
  • Informed consent of the patient's parent or guardian to participate in the study
  • Age one month to 18 years

Exclusion Criteria

  • Risk factors of central venous catheter thrombosis
  • Anti-coagulant or anti-platelet medication use in the past 5 days
  • Major surgery in the last 24 hours
  • Glomerular filtration rate less than 30
  • Thrombocytopenia (platelets less than 50 thousand)
  • Kidney, heart and liver disorders
  • Uncontrolled blood pressure
  • Lumbar puncture in the last 24 hours

Investigators

Similar Trials